Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment Zepbound ...
Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise ...
Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise ...
INDIANAPOLIS (dpa-AFX) - Eli Lilly And Co. (LLY) revealed earnings for its first quarter that increased from the same period last year and beat the Street estimates. The company's earnings totaled ...
Eli Lilly plant nach eigenen Angaben Investitionen in Höhe von 2,3 Milliarden Euro, es sollen bis zu 1000 neue Arbeitsplätze ...
23.04.24 S&P 500-Titel Eli Lilly and-Aktie: So viel Gewinn hätte ein Eli Lilly and-Investment von vor 10 Jahren abgeworfen 14.05.24 S&P 500-Titel Eli Lilly and-Aktie: So viel Gewinn hätte eine ...
In den 1920er Jahren hat Lilly das erste Insulinpräparat Iletin für die bis dahin tödliche Diabetes mellitus entwickelt und in ...
(Reuters) -Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment Zepbound and type 2 diabetes drug Mounjaro. Shares of the company rose ...
(RTTNews) - Eli Lilly And Co. (LLY) revealed earnings for its first quarter that increased from the same period last year and ...